Results GSH levels in blood increased after 1, 3 and 6 months versus baseline at both doses
Individual results may vary and depend on multiple factors including proper administration, lifestyle, and individual physiology.
Similar to the situation in MYC-driven cancer cells, glutamine uptake is enhanced in K-Ras-driven cells via upregulation of SLC1A5 181
Inflammatory Bowel Disease BPC 157 is believed to be beneficial in managing inflammatory bowel syndrome, Crohns disease, and ulcerative colitis
These effects position it as a potential candidate to enhance results when combined with other treatments
For most first-time users, a GHK-Cu dosage of 1 mg/day subcutaneously is a reasonable starting point for anti-aging or skin-focused goals